Literature DB >> 8844622

Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture.

J R Dyer1, B L Gilliam, J J Eron, L Grosso, M S Cohen, S A Fiscus.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is transmitted by infected males in semen. However, the inoculum required for infection is unknown. The ability to collect such information will rely on the availability of reliable quantitative assays of HIV-1 in semen. We examined the comparative performance of NASBA and Amplicor Monitor RT-PCR in quantifying HIV-1 RNA in cell free seminal plasma from seropositive men and correlated the results obtained with viral titres measured by a seminal cell quantitative microculture (QMC) assay. Of samples analysed, 68% and 56% by both NASBA and RT-PCR contained measurable HIV-1 RNA, respectively. Amplification inhibition frequently affected RT-PCR but not NASBA. Excluding samples with complete RT-PCR inhibition, there was 90% qualitative concordance and a strong positive correlation (r = 0.86) of RNA levels measured by the two methods. Comparison of the concentration of HIV-1 RNA in seminal plasma samples, as measured by NASBA, with QMC viral titres indicated that RNA levels probably reflect the infectiousness of whole semen. NASBA is a reliable technique for quantitating HIV-1 RNA in seminal plasma and should become a valuable tool in the study of factors that influence the sexual transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844622     DOI: 10.1016/0166-0934(96)02063-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  37 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.

Authors:  C C Ginocchio; S Tetali; D Washburn; F Zhang; M H Kaplan
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

Review 3.  Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

Authors:  Birgit Deiman; Pierre van Aarle; Peter Sillekens
Journal:  Mol Biotechnol       Date:  2002-02       Impact factor: 2.695

4.  High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

Authors:  P Gupta; J Mellors; L Kingsley; S Riddler; M K Singh; S Schreiber; M Cronin; C R Rinaldo
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

5.  Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma.

Authors:  S A Fiscus; D Brambilla; R W Coombs; B Yen-Lieberman; J Bremer; A Kovacs; S Rasheed; M Vahey; T Schutzbank; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

6.  Applications of competitor RNA in diagnostic reverse transcription-PCR.

Authors:  Steven B Kleiboeker
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting.

Authors:  Tim Schuurman; Richard F de Boer; Anna M D Kooistra-Smid; Anton A van Zwet
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

8.  Ligation with nucleic acid sequence-based amplification.

Authors:  Carmichael Ong; Warren Tai; Aartik Sarma; Steven M Opal; Andrew W Artenstein; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2012-03-23       Impact factor: 5.568

9.  A simple method for amplifying RNA targets (SMART).

Authors:  Stephanie E McCalla; Carmichael Ong; Aartik Sarma; Steven M Opal; Andrew W Artenstein; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2012-06-11       Impact factor: 5.568

10.  Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.

Authors:  Philip L Bulterys; Sudeb C Dalai; David A Katzenstein
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.